Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

Silman, 1993

Drossaers-Bakker, 1999, Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time, Arthritis Rheum, 42, 1854, 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO;2-F

Eberhardt, 1995, Functional impairment and disability in early rheumatoid arthritis: development over 5 years, J Rheumatol, 22, 1037

Pincus, 2001, Premature mortality in patients with rheumatoid arthritis: evolving concepts, Arthritis Rheum, 44, 1234, 10.1002/1529-0131(200106)44:6<1234::AID-ART213>3.0.CO;2-R

Furst, 2002, Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002), Ann Rheum Dis, 61, ii2, 10.1136/ard.61.suppl_2.ii2

2002, American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update, Arthritis Rheum, 46, 328, 10.1002/art.10148

Brennan, 1989, Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis, Lancet, 2, 244, 10.1016/S0140-6736(89)90430-3

Arend, 1995, Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis, Arthritis Rheum, 38, 151, 10.1002/art.1780380202

Choy, 2001, Cytokine pathways and joint inflammation in rheumatoid arthritis, N Engl J Med, 344, 907, 10.1056/NEJM200103223441207

Lipsky, 2000, Infliximab and methotrexate in the treatment of rheumatoid arthritis, N Engl J Med, 343, 1594, 10.1056/NEJM200011303432202

Weinblatt, 2003, Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial, Arthritis Rheum, 48, 35, 10.1002/art.10697

Bathon, 2000, A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis, N Engl J Med, 343, 1586, 10.1056/NEJM200011303432201

Moreland, 1999, Etanercept therapy in rheumatoid arthritis:a randomized, controlled trial, Ann Intern Med, 130, 478, 10.7326/0003-4819-130-6-199903160-00004

Weinblatt, 1999, A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate, N Engl J Med, 340, 253, 10.1056/NEJM199901283400401

Mohler, 1993, Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists, J Immunol, 151, 1548, 10.4049/jimmunol.151.3.1548

Felson, 1995, American College of Rheumatology:preliminary definition of improvement in rheumatoid arthritis, Arthritis Rheum, 38, 727, 10.1002/art.1780380602

van der Heijde, 1993, Development of a disease activity score based on judgment in clinical practice by rheumatologists, J Rheumatol, 20, 579

van Riel, 2000, Clinical outcome measures in rheumatoid arthritis, Ann Rheum Dis, 59, i28, 10.1136/ard.59.suppl_1.i28

van der Heijde, 1989, Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis, Lancet, 1, 1036, 10.1016/S0140-6736(89)92442-2

Lassere, 1999, Smallest detectable difference in radiological progression, J Rheumatol, 26, 731

Hochberg, 1988, A sharper Bonferroni procedure for multiple test of significance, Biometrika, 75, 800, 10.1093/biomet/75.4.800

van der Heijde, 2002, How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion, Arthritis Rheum, 47, 215, 10.1002/art.10181

Weinblatt, 1995, Efficacy of methotrexate in rheumatoid arthritis, Br J Rheumatol, 34, 43, 10.1093/rheumatology/XXXIV.suppl_4.43

Weinblatt, 1999, The role of current strategies in the future treatment of rheumatoid arthritis, Rheumatology, 38, 19

van Vollenhoven, 2003, Etanercept versus etanercept plus methotrexate: a registry based study suggesting that the combination is clinically more efficacious, Arthritis Res Ther, 5, R347, 10.1186/ar1005

Felson, 1998, Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?, Arthritis Rheum, 41, 1564, 10.1002/1529-0131(199809)41:9%3C1564::AID-ART6%3E3.0.CO;2-M

Fries, 1982, The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales, J Rheumatol, 9, 789

Rau, 1996, Healing phenomena of erosive changes in rheumatoid arthritis patients undergoing disease-modifying antirheumatic drug therapy, Arthritis Rheum, 39, 162, 10.1002/art.1780390123

Rau, 2001, Identification of radiologic healing phenomena in patients with rheumatoid arthritis, J Rheumatol, 28, 2608

Sharp, 2003, Repair of erosions in rheumatoid arthritis does occur: results from two studies by the OMERACT subcommittee on healing of erosions, J Rheumatol, 30, 1102

Moreland, 2001, Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis, J Rheumatol, 28, 1238